We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+11.99%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$98.2M
Cap. Flow
% of AUM
95.28%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
111
New
111
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$4.43M |
| 2 |
Microsoft
MSFT
|
+$2.97M |
| 3 |
FEIC
FEI COMPANY
FEIC
|
+$2.86M |
| 4 |
Harvard Bioscience
HBIO
|
+$2.45M |
| 5 |
Calumet Specialty Products
CLMT
|
+$2.34M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.65% |
| 2 | Healthcare | 15.42% |
| 3 | Energy | 13.56% |
| 4 | Financials | 12.08% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
John Wiley & Sons Class A
WLY
$2.72B
| $425K | 0.41% |
+7,700
| New | +$389K |
|
77
Orion Energy Systems
OESX
$41.8M
| $422K | 0.41% |
+6,213
| New | +$329K |
|
78
Novartis
NVS
$294B
| $418K | 0.41% |
+5,803
| New | +$403K |
|
|
FAX
79
abrdn Asia-Pacific Income Fund
FAX
$597M
| $406K | 0.39% |
+70,400
| New | +$406K |
|
|
BTH
80
DELISTED
BLYTH,INC
BTH
| $392K | 0.38% |
+36,005
| New | +$444K |
|
81
ExxonMobil
XOM
$627B
| $378K | 0.37% |
+3,735
| New | +$345K |
|
82
Sony
SONY
$131B
| $339K | 0.33% |
+98,000
| New | +$362K |
|
83
Chevron
CVX
$376B
| $334K | 0.32% |
+2,674
| New | +$323K |
|
84
Nokia
NOK
$54.9B
| $324K | 0.31% |
+40,000
| New | +$301K |
|
85
Gilead Sciences
GILD
$163B
| $300K | 0.29% |
+4,000
| New | +$279K |
|
86
Radiant Logistics
RLGT
$397M
| $294K | 0.29% |
+109,750
| New | +$251K |
|
87
Apple
AAPL
$4.46T
| $274K | 0.27% |
+13,664
| New | +$258K |
|
88
Kinross Gold
KGC
$28.6B
| $274K | 0.27% |
+62,515
| New | +$298K |
|
89
Kayne Anderson Energy Infrastructure Fund
KYN
$2.4B
| $247K | 0.24% |
+6,206
| New | +$228K |
|
90
ConocoPhillips
COP
$142B
| $244K | 0.24% |
+3,452
| New | +$248K |
|
91
AbbVie
ABBV
$433B
| $203K | 0.2% |
+3,840
| New | +$189K |
|
|
NYV
92
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
| $203K | 0.2% |
+15,000
| New | +$202K |
|
93
TETRA Technologies
TTI
$1.26B
| $199K | 0.19% |
+16,100
| New | +$201K |
|
|
PER
94
DELISTED
SANDRIDGE PERMIAN TRUST
PER
| $188K | 0.18% |
+15,900
| New | +$216K |
|
|
IVAC
95
DELISTED
Intevac Inc
IVAC
| $169K | 0.16% |
+22,750
| New | +$138K |
|
96
Lantronix
LTRX
$265M
| $162K | 0.16% |
+103,839
| New | +$158K |
|
|
DXYN
97
DELISTED
Dixie Group Inc
DXYN
| $159K | 0.15% |
+12,050
| New | +$142K |
|
98
Lightpath Technologies
LPTH
$758M
| $157K | 0.15% |
+115,643
| New | +$158K |
|
|
STRP
99
DELISTED
Straight Path Communications Inc.
STRP
| $138K | 0.13% |
+16,830
| New | +$110K |
|
|
DAEG
100
DELISTED
DAEGIS INC
DAEG
| $126K | 0.12% |
+105,451
| New | +$102K |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 111 positions worth $103M. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Novo Nordisk: 254,000 shares worth $4.69M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Healthcare and Energy.
- Penbrook Management's largest Q4 2013 buy was Novo Nordisk: 254,000 shares worth $4.69M.
- Penbrook Management's ten largest holdings make up 27% of its $103M portfolio in Q4 2013.
- Penbrook Management disclosed 111 positions in Q4 2013, its first 13F filing on record.
Based on Penbrook Management's 13F filing for Q4 2013, filed 25 Mar 2014.